文献速递瓣膜病与结构性心脏病

血浆代谢组学揭示主动脉瓣狭窄关键代谢物并提升风险预测

Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies
RSS 订阅 · Heart

该研究基于前瞻性队列与孟德尔随机化方法,分析血浆代谢组学与主动脉瓣狭窄风险的关联。研究识别出39种与主动脉瓣狭窄存在因果关联的代谢物,并进一步筛选出12种关键代谢物。将这些关键代谢物纳入基于临床危险因素的模型后,可显著改善主动脉瓣狭窄的风险预测。

要点

  • 血浆代谢组学分析可识别与主动脉瓣狭窄因果相关的代谢物。
  • 12种关键代谢物可提升基于临床因素的风险预测模型效能。
  • 研究支持将代谢谱分析整合入临床实践以改善风险管理。

核心结论

  • 整合代谢谱分析可改善主动脉瓣狭窄的风险预测与管理。

研究设计与样本

  • 研究采用前瞻性队列研究与孟德尔随机化方法。

主要发现

  • 识别出39种与主动脉瓣狭窄风险存在因果关联的代谢物。
  • 显著代谢物包括载脂蛋白B、含载脂蛋白B的脂蛋白颗粒及脂蛋白亚类中的脂质成分。
  • 使用LASSO回归筛选出12种关键代谢物。

关键数值与推荐

  • 将12种关键代谢物纳入临床危险因素模型后,显著改善了主动脉瓣狭窄的风险预测。

临床怎么用

  • 研究结果支持将代谢谱分析整合入临床实践,以改善主动脉瓣狭窄的风险预测与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

WHAT IS ALREADY KNOWN ON THIS TOPIC Traditional lipid markers including high-density lipoprotein cholesterol and low-density lipoprotein cholesterol have been established as associated with aortic stenosis (AS) risk in previous studies. The relationship between comprehensive plasma metabolomic profiles and AS risk remains incompletely understood. WHAT THIS STUDY ADDS Through comprehensive metabolomic analysis, we identified 39 metabolites with causal associations to AS risk, notably apolipoprotein B, apolipoprotein B-containing lipoprotein particles and lipid constituents within lipoprotein subclasses. Using LASSO (least absolute shrinkage and selection operator) regression, we identified 12 key metabolites that significantly improved AS risk prediction when incorporated into clinical risk factors-based model. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Our findings support integrating metabolic profiling into clinical practice to improve AS risk prediction and management. Introduction Aortic stenosis (AS) is the leading form of valvular heart...

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Heart:Plasma metabolomics uncovers key metabolites and enhances prediction of aortic stenosis: insights from prospective cohort and Mendelian randomisation studies

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。